copyright and Wegovy, two recent breakthroughs in the field of weight management, have attracted significant attention for their impressive results. These medications, both belonging to a class called Ozempic GLP-1 receptor agonists, work by regulating the body's natural processes to reduce appetite and optimize insulin sensitivity. Early clinical